Unknown

Dataset Information

0

The ?133p53? isoform promotes an immunosuppressive environment leading to aggressive prostate cancer.

ABSTRACT: Prostate cancer is the second most common cancer in men, for which there are no reliable biomarkers or targeted therapies. Here we demonstrate that elevated levels of ?133TP53? isoform characterize prostate cancers with immune cell infiltration, particularly T cells and CD163+ macrophages. These cancers are associated with shorter progression-free survival, Gleason scores???7, and an immunosuppressive environment defined by a higher proportion of PD-1, PD-L1 and colony-stimulating factor 1 receptor (CSF1R) positive cells. Consistent with this, RNA-seq of tumours showed enrichment for pathways associated with immune signalling and cell migration. We further show a role for hypoxia and wild-type p53 in upregulating ?133TP53 levels. Finally, AUC analysis showed that ?133TP53? expression level alone predicted aggressive disease with 88% accuracy. Our data identify ?133TP53? as a highly accurate prognostic factor for aggressive prostate cancer.

SUBMITTER: Kazantseva M 

PROVIDER: S-EPMC6702175 | biostudies-literature | 2019 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Prostate cancer is the second most common cancer in men, for which there are no reliable biomarkers or targeted therapies. Here we demonstrate that elevated levels of Δ133TP53β isoform characterize prostate cancers with immune cell infiltration, particularly T cells and CD163+ macrophages. These cancers are associated with shorter progression-free survival, Gleason scores ≥ 7, and an immunosuppressive environment defined by a higher proportion of PD-1, PD-L1 and colony-stimulating factor 1 recep  ...[more]

Similar Datasets

Unknown The p53 isoform ?133p53? promotes cancer stem cell potential.
| S-EPMC4400643 | biostudies-literature
Unknown Coordinate loss of MAP3K7 and CHD1 promotes aggressive prostate cancer.
| S-EPMC4531265 | biostudies-literature
Unknown Indoleamine 2,3-dioxygenase promotes peritoneal metastasis of ovarian cancer by inducing an immunosuppressive environment.
| S-EPMC4317851 | biostudies-other
Unknown ∆133p53 isoform promotes tumour invasion and metastasis via interleukin-6 activation of JAK-STAT and RhoA-ROCK signalling.
| S-EPMC5772473 | biostudies-literature
Unknown Nuclear Kaiso indicates aggressive prostate cancers and promotes migration and invasiveness of prostate cancer cells.
| S-EPMC3483816 | biostudies-literature
Unknown Regulation of the interferon-gamma (IFN-?) pathway by p63 and ?133p53 isoform in different breast cancer subtypes.
| S-EPMC6044385 | biostudies-literature
Unknown Aberrant hypomethylation-mediated CD147 overexpression promotes aggressive tumor progression in human prostate cancer.
| S-EPMC6918814 | biostudies-literature
Unknown Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins.
| S-EPMC3282076 | biostudies-literature
Unknown Inherited susceptibility for aggressive prostate cancer.
| S-EPMC3568760 | biostudies-literature
Unknown Neuroendocrine and Aggressive-Variant Prostate Cancer.
| S-EPMC7765615 | biostudies-literature